The Gross Margin of Cynata Therapeutics Ltd (CYP.AX) is 85.71%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-06-30 | 85.71% |